Sector: MedicalOncolytics Biotech, Inc. (NASDAQ: ONCY)
Headlines
- Oncolytics Biotech(R) Inc. Closes US$12.75 Million Unit Offering
Nov 23, 2009 09:20 AM | CCI, ONCY
- TSX pokes into positive territory
Nov 18, 2009 04:51 PM | ABX, AEM, CRM
- IIROC: Resumption; Oncolytics Biotech Inc.
Nov 18, 2009 10:14 AM | ONCY
- IIROC: Halt; Oncolytics Biotech Inc.
Nov 18, 2009 10:14 AM | ONCY
- Investment Industry Regulatory Organization of Canada - Trade Resumption - Oncolytics Biotech Inc. - ONC
Nov 18, 2009 09:47 AM | ONCY
- Investment Industry Regulatory Organization of Canada - Trading Halt - Oncolytics Biotech Inc. - ONC
Nov 18, 2009 09:45 AM | ONCY
- Oncolytics Biotech(R) Inc. Announces Unit Offering
Nov 17, 2009 05:01 PM | ONCY
- Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting
Nov 17, 2009 08:31 AM | ONCY
- Oncolytics Biotech(R) Inc. Collaborators to Present Updated Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting
Nov 16, 2009 07:31 AM | ONCY
- Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting
Nov 06, 2009 09:02 AM | ONCY
- Media Advisory - Oncolytics Biotech Inc. to Present at Rodman & Renshaw 11th Annual Healthcare Conference
Sep 08, 2009 11:28 AM | ONCY
- Oncolytics Biotech Inc. Successfully Completes 100-Litre cGMP Production of REOLYSIN(R)
Jul 27, 2009 07:30 AM | ONCY
- Oncolytics Biotech(R) Inc. Completes Lyophilization Process for REOLYSIN(R)
Jul 20, 2009 07:30 AM | ONCY
- Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC
Jul 16, 2009 07:30 AM | ONCY
- Oncolytics Biotech(R) Inc. Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting
Jul 15, 2009 07:30 AM | ONCY
- Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carboplatin Head and Neck Cancer Trial
Jul 02, 2009 07:31 AM | ONCY
- Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting
Jun 01, 2009 07:31 AM | ONCY
- Oncolytics Biotech(R) Inc.'s Research Collaborators to Present Data on REOLYSIN(R) Clinical Trials at ASCO Conference
May 14, 2009 06:01 PM | ONCY
- Oncolytics(R) Biotech Inc. Completes Patient Enrolment in U.S. Phase 2 Sarcoma Study
May 12, 2009 07:31 AM | ONCY
- Oncolytics Biotech(R) Inc. Announces 2009 First Quarter Results
May 05, 2009 04:30 PM | ONCY
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ONCY
|
Compare to S&P
|
| YTD |
123.14 %
|
84.68 %
|
| 4 Weeks |
-14.77 %
|
-15.69 %
|
| 12 Weeks |
15.88 %
|
9.25 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 37.50 %
|
|
EPS Growth in Last Year: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
